Laval University is a public research university in Québec City, Québec, Canada. The University was founded by royal charter issued by Queen Victoria in 1852, with roots in the founding of the Séminaire ...

During the past decade, Laval University conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 7 clinical trials were completed, i.e. on average, 15.2% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 5 clinical trials were completed. i.e. 41.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Laval University" #1 sponsor was "Laval University" with 36 trials, followed by "LivaNova" with 3 trials sponsored, "Ottawa Heart Institute Research Corporation" with 3 trials sponsored, "University of British Columbia" with 3 trials sponsored and "University of Alberta" with 3 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Laval University" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 14 trials as a collaborator, "Laval University" with 6 trials as a collaborator, "McGill University" with 3 trials as a collaborator, "The Finnish Funding Agency for Technology and Innovation (TEKES)" with 3 trials as a collaborator and "Merck Sharp & Dohme LLC" with 2 trials as a collaborator. Other collaborators include 51 different institutions and companies that were collaborators in the rest 56 trials.

According to Clinical.Site data, the most researched conditions in "Laval University" are "Obesity" (5 trials), "Gut Microbiota" (4 trials), "Metabolic Syndrome" (4 trials), "Asthma" (3 trials) and "Atrial Fibrillation" (3 trials). Many other conditions were trialed in "Laval University" in a lesser frequency.

Most popular intervention types in "Laval University" are "Other" (22 trials), "Device" (16 trials), "Drug" (14 trials), "Behavioral" (13 trials) and "Dietary Supplement" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Advanced Imaging" (2 trials), "Cognitive Therapy" (2 trials), "Sitagliptin" (2 trials) and "Standard Imaging" (2 trials). Other intervention names were less common.

The vast majority of trials in "Laval University" are 64 trials for "All" genders, 6 trials for "Male" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Laval University". undefined are not yet recruiting, 18 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 34 completed trials in Laval University, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Laval University, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 42 trials that are defined as “Not Applicable".

Laval University has several departments that took part in Clinical trials: "Centre De Recherche En Infectiologie" - 3 trials, "Center for Interdisciplinary Research in Rehabilitation and Social Integration (CIRRIS)" - 3 trials